|
1
|
Murray CJ and Lopez AD: Mortality by cause
for eight regions of the world: Global Burden of Disease Study.
Lancet. 349:1269–1276. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tantry US, Bliden KP and Gurbel PA:
Resistance to anti-platelet drugs: Current status and future
research. Expert Opin Pharmacother. 6:2027–2045. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cox D: Oral GPIIb/IIIa antagonists: What
went wrong? Curr Pharm Des. 10:1587–1596. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Herbert JM, Hérault JP, Bernat A, Savi P,
Schaeffer P, Driguez PA, Duchaussoy P and Petitou M: SR123781A, a
synthetic heparin mimetic. Thromb Haemost. 85:852–860.
2001.PubMed/NCBI
|
|
5
|
Petitou M, Hérault JP, Bernat A, Driguez
PA, Duchaussoy P, Lormeau JC and Herbert JM: Synthesis of
thrombin-inhibiting heparin mimetics without side effects. Nature.
398:417–422. 1999. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Dogné JM, Hanson J, de Leval X, Masereel
B, Kolh P and Pirotte B: New developments on thromboxane
modulators. Mini Rev Med Chem. 4:649–657. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhao Z, Arnaiz DO, Griedel B, Sakata S,
Dallas JL, Whitlow M, Trinh L, Post J, Liang A, Morrissey MM and
Shaw KJ: Design, synthesis, and in vitro biological activity of
benzimidazole based factor Xa inhibitors. Bioorg Med Chem Lett.
10:963–966. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kucheryavenko AF, Spasov AA, Petrov VI and
Anisimova VA: Antiaggregant activity of a new benzimidazole
derivative. Bull Exp Biol Med. 156:796–798. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Greinacher A, Alban S, Dummel V, Franz G
and Mueller-Eckhardt C: Characterization of the structural
requirements for a carbohydrate based anticoagulant with a reduced
risk of inducing the immunological type of heparin-associated
thrombocytopenia. Thromb Haemost. 74:886–892. 1995.PubMed/NCBI
|
|
10
|
Lin C, Lai PT, Liao SK, Hung WT, Yang WB
and Fang JM: Using molecular iodine in direct oxidative
condensation of aldoses with diamines: An improved synthesis of
aldo-benzimidazoles and aldo-naphthimidazoles for carbohydrate
analysis. J Org Chem. 73:3848–3853. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sheu JR, Lee CR, Lin CH, Hsiao G, Ko WC,
Chen YC and Yen MH: Mechanisms involved in the antiplatelet
activity of Staphylococcus aureus lipoteichoic acid in human
platelets. Thromb Haemost. 83:777–784. 2000.PubMed/NCBI
|
|
12
|
Westerfield M: The Zebrafish Book: A Guide
for the Laboratory Use of Zebrafish (Brachydanio rerio). University
of Oregon Press; Eugene, OR: 1993
|
|
13
|
Mackman N: Triggers, targets and
treatments for thrombosis. Nature. 451:914–918. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kang WS, Chung KH, Chung JH, Lee JY, Park
JB, Zhang YH, Yoo HS and Yun YP: Antiplatelet activity of green tea
catechins is mediated by inhibition of cytoplasmic calcium
increase. J Cardiovasc Pharmacol. 38:875–884. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Tyers M, Rachubinski RA, Stewart MI,
Varrichio AM, Shorr RG, Haslam RJ and Harley CB: Molecular cloning
and expression of the major protein kinase C substrate of
platelets. Nature. 333:470–473. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Toth-Zsamboki E, Oury C, Cornelissen H, De
Vos R, Vermylen J and Hoylaerts MF: P2X1-mediated ERK2 activation
amplifies the collagen-induced platelet secretion by enhancing
myosin light chain kinase activation. J Biol Chem. 278:46661–46667.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Nofal ZM, Soliman EA, Abd El-Karim SS, El
Zahar MI, Srour AM, Sethumadhavan S and Maher TJ: Novel
benzimidazole derivatives as expected anticancer agents. Acta Pol
Pharm. 68:519–534. 2011.PubMed/NCBI
|
|
18
|
Unsworth AJ, Smith H, Gissen P, Watson SP
and Pears CJ: Submaximal inhibition of protein kinase C restores
ADP-induced dense granule secretion in platelets in the presence of
Ca2+. J Biol Chem. 286:21073–21082. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Roberts DE, McNicol A and Bose R:
Mechanism of collagen activation in human platelets. J Biol Chem.
279:19421–19430. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Roberts DE and Bose R: Reverse mode
Na+/Ca2+ exchange in the collagen activation of human
platelets. Ann NY Acad Sci. 976:345–349. 2002. View Article : Google Scholar
|
|
21
|
Lu WJ, Lee JJ, Chou DS, Jayakumar T, Fong
TH, Hsiao G and Sheu JR: A novel role of andrographolide, an
NF-kappa B inhibitor, on inhibition of platelet activation: The
pivotal mechanisms of endothelial nitric oxide synthase/cyclic GMP.
J Mol Med (Berl). 89:1261–1273. 2011. View Article : Google Scholar
|
|
22
|
Jayakumar T, Chen WF, Lu WJ, Chou DS,
Hsiao G, Hsu CY, Sheu JR and Hsieh CY: A novel antithrombotic
effect of sulforaphane via activation of platelet adenylate
cyclase: Ex vivo and in vivo studies. J Nutr Biochem. 24:1086–1095.
2013. View Article : Google Scholar
|
|
23
|
Chang Y, Hsu WH, Lu WJ, Jayakumar T, Liao
JC, Lin MJ, Wang SH, Geraldine P, Lin KH and Sheu JR: Inhibitory
mechanisms of CME-1, a novel polysaccharide from the mycelia of
Cordyceps sinensis, in platelet activation. Curr Pharm Biotechnol.
16:451–461. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Rakesh KS, Jagadish S, Vinayaka AC,
Hemshekhar M, Paul M, Thushara RM, Sundaram MS, Swaroop TR, Mohan
CD, Basappa, et al: A new ibuprofen derivative inhibits platelet
aggregation and ROS mediated platelet apoptosis. PLoS One.
9:e1071822014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Bugaud F, Nadal-Wollbold F, Lévy-Toledano
S, Rosa JP and Bryckaert M: Regulation of c-jun-NH2 terminal kinase
and extracellular-signal regulated kinase in human platelets.
Blood. 94:3800–3805. 1999.PubMed/NCBI
|
|
26
|
Coulon L, Calzada C, Moulin P, Véricel E
and Lagarde M: Activation of p38 mitogen-activated protein
kinase/cytosolic phospholipase A2 cascade in hydroperoxide-stressed
platelets. Free Radic Biol Med. 35:616–625. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Tyers M, Haslam RJ, Rachubinski RA and
Harley CB: Molecular analysis of pleckstrin: The major protein
kinase C substrate of platelets. J Cell Biochem. 40:133–145. 1989.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lu WJ, Chang NC, Jayakumar T, Liao JC, Lin
MJ, Wang SH, Chou DS, Thomas PA and Sheu JR: Ex vivo and in vivo
studies of CME-1, a novel polysaccharide purified from the mycelia
of Cordyceps sinensis that inhibits human platelet activation by
activating adenylate cyclase/cyclic AMP. Thromb Res. 134:1301–1310.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lin KH, Kuo JR, Lu WJ, Chung CL, Chou DS,
Huang SY, Lee HC and Sheu JR: Hinokitiol inhibits platelet
activation ex vivo and thrombus formation in vivo. Biochem
Pharmacol. 85:1478–1485. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
He N, Li X, Feng D, Wu M, Chen R, Chen T,
Chen D and Feng X: Exploring the toxicity of a bismuth-asparagine
coordination polymer on the early development of zebrafish embryos.
Chem Res Toxicol. 26:89–95. 2013. View Article : Google Scholar
|
|
31
|
Chen MC, Zhou B, Zhang K, Yuan YC, Un F,
Hu S, Chou CM, Chen CH, Wu J, Wang Y, et al: The novel
ribonucleotide reductase inhibitor COH29 inhibits DNA repair in
vitro. Mol Pharmacol. 87:996–1005. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sittaramane V, Padgett J, Salter P,
Williams A, Luke S, McCall R, Arambula JF, Graves VB, Blocker M,
Van Leuven D, et al: Discovery of quinoline-derived trifluoromethyl
alcohols, determination of their in vivo toxicity and anticancer
activity in a zebrafish embryo model. ChemMedChem. 10:1802–1807.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yang J and Chan KM: Evaluation of the
toxic effects of brominated compounds (BDE-47, 99, 209, TBBPA) and
bisphenol A (BPA) using a zebrafish liver cell line, ZFL. Aquat
Toxicol. 159:138–147. 2015. View Article : Google Scholar
|
|
34
|
Sathler PC, Santana M, Lourenço AL,
Rodrigues CR, Abreu P, Cabral LM and Castro HC: Human thromboxane
synthase: Comparative modeling and docking evaluation with the
competitive inhibitors Dazoxiben and Ozagrel. J Enzyme Inhib Med
Chem. 29:527–531. 2014. View Article : Google Scholar
|
|
35
|
Lourenço AL, Saito MS, Dorneles LE, Viana
GM, Sathler PC, Aguiar LC, de Pádula M, Domingos TF, Fraga AG,
Rodrigues CR, et al: Synthesis and antiplatelet activity of
antithrombotic thiourea compounds: Biological and
structure-activity relationship studies. Molecules. 20:7174–7200.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Liedtke AJ, Crews BC, Daniel CM, Blobaum
AL, Kingsley PJ, Ghebreselasie K and Marnett LJ:
Cyclooxygenase-1-selective inhibitors based on the
(E)-2′-des-methyl-sulindac sulfide scaffold. J Med Chem.
55:2287–2300. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Reyes JJ, De La Cruz JP, Muñoz-Marin J,
Guerrero A, Lopez-Villodres JA, Madrona A, Espartero JL and
Gonzalez-Correa JA: Antiplatelet effect of new lipophilic
hydroxytyrosol alkyl ether derivatives in human blood. Eur J Nutr.
52:591–599. 2013. View Article : Google Scholar
|
|
38
|
Guo C, Liu S, Guo Y, Yin Y, Lin J, Chen X
and Sun MZ: Comparative function-structural analysis of
antiplatelet and antiradical activities of flavonoid
phytochemicals. J Anim Plant Sci. 24:926–935. 2014.
|
